Researchers are making progress in targeting ROR1 in hematological cancers, with advancements being explored in cell therapy. The development of new therapeutic strategies, including CAR-T cell therapy, is being investigated for various types of blood cancers. Studies and research highlights from several institutions and organizations are contributing to the evolving landscape of treatments for these cancers.